CPH-82 (Reumacon) versus auranofin (Ridaura): a 36-week study of their respective onset of action rates in RA.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/EC4B06F6.svg?ark=w1%2F20260515%2FEC4B06F6)](https://nobleid.org/work/w1/20260515/EC4B06F6)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors